Company name: Curo Medical
Description: Producer of cannabis pills and sublingual strips created for medical use. The company uses an algorithmic extraction process to manipulate temperature so that it is able to extract the cannabinoids, terpenes and water-based materials that are in the plant, enabling patients to enjoy the relief offered by cannabis in a healthier and consistent manner.
Industry: Healthcare | Group: | Code:
State: Tel Aviv District
Start up capital raised (USD Million): 2.00
Business status: Pre-Clinical Trials
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company is reportedly seeking angel funding from undisclosed investors. Previously, the company raised $2 million of angel funding on an undisclosed date.
Number of active investors:
Profile last updated: 10-Feb-2020
Last known valuation:
Last known valuation date: